AI Article Synopsis
- Amyloidosis is a rare condition characterized by the accumulation of insoluble amyloid proteins in organs, leading to potential organ failure and mortality.
- It impacts fewer than 200,000 individuals in the U.S., classifying it as a rare disease per the National Institutes of Health.
- Identifying the specific type of amyloid protein involved is crucial for prognosis and treatment, as approaches differ based on the underlying cause.
Article Abstract
Amyloidosis is a rare disorder in which insoluble amyloid proteins are deposited in body organs, causing abnormal protein build-up in tissues and eventually leading to organ dysfunction and death. It affects less than 200,000 people in the United States, classifying it as a rare disease according to the National Institutes of Health. Definitive determination of the underlying protein is critical since prognosis and treatment of amyloidosis can vary widely depending on the responsible protein. The following paper describes the various types and clinical features of amyloidosis and provides an overview of current diagnostic tools and therapies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487569 | PMC |
| http://dx.doi.org/10.14797/mdcj-8-3-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!